Arabinosylated lipoarabinomannan-mediated protection in visceral leishmaniasis through up-regulation of Toll-Like receptor 2 signaling: An immunoprophylactic approach

Journal of Infectious Diseases

Volumn 202, Issue 1, 2010, Pages 145-155

  Bhattacharya, Parna ^a   Bhattacharjee, Surajit ^a   Gupta, Gaurav ^a   Majumder, Saikat ^a   Adhikari, Anupam ^a   Mukherjee, Asok ^a   Majumdar, Suchandra Bhattacharyya ^a   Saha, Bhaskar ^b   Majumdar, Subrata ^a  

^a BOSE INSTITUTE   (India)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOARABINOMANNAN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; IMMUNOLOGIC FACTOR; LIPOPOLYSACCHARIDE; TLR2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; FEMALE; IMMUNOPROPHYLAXIS; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; VISCERAL LEISHMANIASIS; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; PARASITOLOGY; PERITONEUM MACROPHAGE; RNA INTERFERENCE;

ANIMALS; CELLS, CULTURED; FEMALE; IMMUNOLOGIC FACTORS; LEISHMANIASIS, VISCERAL; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; UP-REGULATION;

EID: 77953710258     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/653210     Document Type: Article

References (37)

1. Dey R, Majumder N, Majumdar SB, et al. Induction of'host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice. Scand I Immunol 2007; 66: 671-683.
2. Titus RG, Gueiros-Filho FJ, de Freitas LA, Beverley SM. Development of sate live Leishmania vaccine by gene replacement. Proc Natl Acad Sci. U S A 1995; 92: 10267-10271.
3. Modabber F. Experiences with vaccines against cutaneous leishmaniasis: of men and mice. Parasitology 1989; 98(suppl): S49-S60. (Pubitemid 19124317)
4. Mayrink W, Williams P, da Costa CA, et al. An experimental vaccine against American dermal leishmaniasis: experience in the state of Espirito Santo Brazil. Ann Trop Med Parasitol 1985; 79: 259-269. (Pubitemid 15227241)
5. Rhee EG, Mendez S, Shah JA, et al. Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection. J Exp Med 2002; 195: 1565-1573.
6. Underhill DM, Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 2002; 14: 103-110. (Pubitemid 34085113)
7. Medzhitov R, Janeway CA Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 1997; 9: 4-9. (Pubitemid 27095892)
8. Netea MG, Van der Graaf C, Van der Meer JW, Kullberg BJ. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J Leukoc Biol 2004; 75: 749-755.
9. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999; 163: 1-5. (Pubitemid 29295815)
10. Chandra D, Naik S. Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage/ monocytic lineage by modulating MAPK pathways through a contactdependent mechanism. Clin Exp Immunol 2008; 154: 224-234.
11. Wieland CW, Knapp S, Florquin S, et al. Non-mannose-capped lipoarabinomannan induces lung inflammation via toll-like receptor 2. Am J Respir Crit Care Med 2004; 170: 1367-1374. (Pubitemid 39662749)
12. Majumder N, Bhattacharjee S, Dey R, et al. Arabinosylated lipoarabinomannan modulates the impaired cell mediated immune response in Mycobacterium tuberculosis H37Rv infected C57BL/6 mice. Microbes Infect 2008; 10: 349-357.
13. Bhattacharjee S, Majumder N, Bhattacharyya P, Bhattacharyya S, Majumdar S. Immunomodulatory role of arabinosylated lipoarabinomannan on Leishmania donovani infected murine macrophages. Indian J Biochem Biophys 2007; 44: 366-372.
14. Hart DT, Vickerman K, Coombs GH, Quick A. Simple method for purifying L. mexicana amastigotes in large numbers. Parasitology 1981; 82: 345-355.
15. Majumder N, Dey R, Mathur RK, et al. An unusual pro-inflammatory role of interleukin-10 induced by arabinosylated lipoarabinomannan in murine peritoneal macrophages. Glycoconj J 2006; 23: 675-686. (Pubitemid 44934191)
16. Fahey TJ, Tracey KJ, Tekamp-Olson P, et al. Macrophage inflammatory protein-1 modulates macrophage function. J Immunol 1992; 148: 2764-2769.
17. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from Polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979; 76: 4350-4354. (Pubitemid 9256559)
18. Majumdar S, Kane LH, Rossi MW, et. al. Protein kinase C isotypes and signal transduction in human neutrophils: selective substrate specificity of calcium dependent β-PKC and novel calcium independent n-PKC. Biochim Biophys Acta 1993; 1176: 276-286.
19. Ghosh S, Bhattacharyya S, Sirkar M, et al. Leishmania donovani suppresses activator protein-1 and NF-kB in host macrophages via ceramide generation: involvement of extracellular signal regulated kinase. Infect Immun 2002; 70: 6828-6838.
20. Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-138. (Pubitemid 13203451)
21. Murray HW, Miralles GD, Stoeckle MY, McDermott DF. Role and effect of IL-12 in experimental visceral leishmaniasis. J Immunol 1993; 151: 929-938. (Pubitemid 23215759)
22. Basu R, Bhaumik S, Basu JM, et al. Kinetoplastid membrane protein11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1 and Th2-like responses in visceral leishmaniasis. J Immunol 2005; 174: 7160-7171.
23. Kropf P, Freudenberg MA, Modolell M, et al. Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect Immun 2004; 72: 1920-1928. (Pubitemid 38419902)
24. Nagpal K, Plantinga TS, Wong J, et al. A. TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling. J Biol Chem 2009; 284: 25742-25748.
25. Liu G, Park YJ, Abraham E. Interleukin-1 receptor-associated kinase (IRAK)-1-mediated NF-kappaB activation requires cytosolic and nuclear activity. FASEB J 2008; 22: 2285-2296. (Pubitemid 351948647)
26. Kobayashi K, Hernandez LD, Galán JE, et al. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002; 110: 191-202. (Pubitemid 34876547)
27. He L, Wu X, Siegel R, Lipsky PE. TRAF6 regulates cell fate decisions by inducing caspase 8-dependent apoptosis and the activation of NF-kappaB. J Biol Chem 2006; 281: 11235-11249. (Pubitemid 43855549)
28. Verstak B, Nagpal K, Bottomley SP, Golenbock DT, Hertzog PJ, Mansell A. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-KB proinflammatory responses. J Biol Chem 2009; 284: 24192-24203.
29. Denis M. Interferon-gamma treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol 1991; 132: 150-157.
30. Teixeira MJ, Teixeira CR, Andrade BB, Barral-Netto M, Barral A. Chemokines in host-parasite interactions in leishmaniasis. Trends Parasitol 2006; 22: 32-40.
31. Das G, Vohra H, Rao K, Saha B, Mishra GC. Leishmania donovani infection of a susceptible host results in CD4+ T-cell apoptosis and decreased Th1 cytokine production. Scand J Immunol 1999; 49: 307-310.
32. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995; 13: 151-177.
33. 2 and NO effector mechanisms. Mycopathologia 2008; 166: 17-23.
34. Alexander J, Bryson K. T helper (h) l\Th2 and leishmania: paradox rather than paradigm. Immunol Lett 2005; 99: 17-23. (Pubitemid 40718928)
35. Hajishengallis G, Wang M, Liang S. Induction of distinct TLR2-mediated proinflammatory and proadhesive signaling pathways in response to Porphyromonas gingivalis fimbriae. J Immunol 2009; 182: 6690-6696.
36. Fischer J, Suire C, Hale-Donze H. Toll-Like receptor 2 recognition of the microsporidia Encephalitozoon spp. induces nuclear translocation of NF-κB and subsequent inflammatory responses. Infect Immun 2008; 76: 4737-4744.
37. Murray HW, Lu CM, Brooks EB, et al. Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis. Infect Immun 2003;71: 6453-6462. (Pubitemid 37337705)